When Zika began to emerge as a potential epidemic, Barton Haynes, director of the Duke Human Vaccine Institute (DHVI), told the researchers in the DHVI’s Regional Biocontainment Laboratory to "get ready to face this epidemic.” This early preparation laid the groundwork for the rapid development and initial testing of a Zika candidate vaccine.
The Duke Global Health Institute (DGHI) and its Maternal, Adolescent and Child Health initiative are sponsoring a three-event speaker series featuring DGHI faculty members as well as guests from other institutions. Events will take place on March 23, March 27 and April 21
DGHI research scholar Dori Steinberg is the lead author on a Viewpoint piece published in last week’s Journal of the American Medical Association (JAMA) that examines why the 20-year-old DASH (short for Dietary Approaches to Stop Hypertension) diet hasn’t been widely adopted by individuals with high blood pressure.
In Uganda, where about 700,000 people are living with untreated epilepsy due to traumatic brain injuries and birth defects, there are only four neurologists who can treat the disease with medication. DGHI professor Michael Haglund is determined to change the game for Ugandan epilepsy patients, and he’s laying the groundwork with a new grant from the UCB Societal Responsibility Fund to establish the Uganda Epilepsy Centers of Excellence.
In a fifth wave of human illness since their discovery in 2013, H7N9 avian influenza viruses in China have recently evolved to cause more severe disease in chickens and more human cases than in previous waves. We talked with Gregory Gray, professor of medicine, environmental health and global health, to get his perspective on controlling the H7N9 outbreak and the importance of a One Health approach.
A new series of papers on Syndemics just published by The Lancet provides an innovative way to think about how diseases cluster together within certain populations. Brandon Kohrt, assistant professor of psychiatry, global health and cultural anthropology, co-authored one of the articles in the series.
A new report co-authored by faculty and staff from the Duke-Margolis Center for Health Policy, the Duke Global Health Institute (DGHI) and DGHI’s Center for Policy Impact in Global Health examines opportunities to strengthen the United State government’s role in developing global health technologies.
Twenty-five DGHI-affiliated authors—including faculty, staff and alumni—recently shared new discoveries on a variety of global health topics in peer-reviewed publications.
With funding from Duke’s Provost and Vice Provost for Interdisciplinary Studies, two Duke Global Health Institute (DGHI)-led teams have initiated new multidisciplinary collaborations.
Since 2012, Nimmi Ramanujam, professor of biomedical engineering and global health and director of the Center for Global Women’s Health Technologies and her research team have been developing and testing a portable colposcope, called the “Pocket Colposcope,” to increase access to cervical cancer screening in primary care settings. Last month, 20 of these devices were produced for distribution to international partners.